Prasco’s new strategic partnership with Frontier Scientific Solutions is another example of how pharmaceutical companies are moving beyond traditional 3PL partnerships and instead choosing to build logistics capabilities specifically designed for high-risk, high-value products.
The announcement reflects a larger trend in the life sciences supply chain: As products become more sensitive to temperature and regulatory scrutiny tightens, manufacturers are increasingly demanding pharmaceutical-focused logistics models rather than generic cold chain services.
“Partnering with Frontier enhances our ability to ensure product integrity and security to our partners and customers,” Prasco CEO Chris Arrington said in a news release. “Using Frontier’s state-of-the-art facilities and dedicated temperature-controlled aircraft, we are solving key industry challenges such as losses, theft and supply shortages, which lead to public health risks and financial losses,” Arrington added.
For Prasco, a long-standing player and supplier of licensed generics and branded pharmaceutical products, this partnership represents an increased focus on lifecycle integration. With more than 130 products and a network that includes 65 innovators, Prasco has reached a scale where logistics reliability is no longer just a cost center. This is a competitive differentiator. By aligning with Frontier, the company gains good manufacturing practice (cGMP) compliant warehousing, trusted transportation assets and a logistics partner that positions itself squarely in the life sciences vertical rather than the broad transportation categories.
Frontier, in turn, is building a platform designed to address some of the biggest vulnerabilities in pharmaceutical shipping, cargo theft, time-temperature excursions and product damage, issues that have grown alongside the sector’s rapid expansion.
“Frontier’s mission is to provide world-class logistics and supply chain solutions to the life sciences industry and companies like Prasco that are transforming access to critical medicines,” Steve Uebele, CEO of Frontier Scientific Solutions, said in a statement. “This partnership underscores the growing importance of specialized logistics. Prasco and Frontier set a new standard for pharmaceutical logistics. Together, we aim to provide best-in-class solutions for a market that is expected to grow 35-45% over the next five years,” Yubel said.
This partnership reflects a changing market: As the US pharmaceutical landscape becomes more complex, manufacturers want logistics partners that can meet them at the regulatory and operational level where they operate. This means real-time visibility, robust quality monitoring, patient-centered care standards, and an infrastructure built specifically to protect valuable medicines across volatile supply networks.
Vertical specialization continues to outpace a broad service portfolio. Providers hoping to remain relevant in the pharmaceutical sector will need to invest more deeply in compliant infrastructure, quality systems and risk mitigation technologies. And for manufacturers, Prasco’s move suggests that more companies may be moving toward hybrid or shared logistics models, giving them tighter control and greater assurance of product integrity from factory to patient.
The post Prasco & Frontier Proprietary Logistics: A Pharmaceutical Game Changer appeared first on FreightWaves.
About the Author
